Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
13 01 2023
Historique:
received: 06 12 2022
revised: 06 01 2023
accepted: 11 01 2023
entrez: 20 1 2023
pubmed: 21 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

We present the case of a 64-year-old man diagnosed with large B-cell lymphoma who relapsed twice after standard-of-care therapy. Due to persisting cytopenia, Next generation sequencing analysis was performed, revealing a small

Identifiants

pubmed: 36661736
pii: curroncol30010087
doi: 10.3390/curroncol30010087
pmc: PMC9858310
doi:

Substances chimiques

Antigens, CD19 0
Receptors, Chimeric Antigen 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1146-1150

Références

N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Haematologica. 2020 Apr;105(4):864-869
pubmed: 32193253
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Bone Marrow Transplant. 2019 Oct;54(10):1643-1650
pubmed: 30809033
Blood Adv. 2021 Aug 10;5(15):2982-2986
pubmed: 34342642
Cancer Res. 2006 Dec 15;66(24):11565-70
pubmed: 17178846
Haematologica. 2021 Oct 01;106(10):2667-2672
pubmed: 32732355
Lancet Oncol. 2019 Jan;20(1):31-42
pubmed: 30518502
Ann Oncol. 2021 Jan;32(1):34-48
pubmed: 33098993
Blood Adv. 2020 Aug 11;4(15):3776-3787
pubmed: 32780846
Blood Cancer Discov. 2022 Sep 6;3(5):382-384
pubmed: 35896010
Blood Cancer Discov. 2022 Sep 6;3(5):385-393
pubmed: 35533245
EJHaem. 2021 Nov 21;3(Suppl 1):32-38
pubmed: 35844301
Blood Adv. 2022 Mar 22;6(6):1941-1946
pubmed: 35008107
Best Pract Res Clin Haematol. 2021 Sep;34(3):101287
pubmed: 34625233
Am J Hematol. 2018 Jun;93(6):E152-E154
pubmed: 29575088
Cancers (Basel). 2022 Mar 15;14(6):
pubmed: 35326654
Biol Blood Marrow Transplant. 2020 Jan;26(1):26-33
pubmed: 31419568
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Nat Med. 2020 Oct;26(10):1549-1556
pubmed: 32747829
Transplant Cell Ther. 2021 Mar;27(3):222-229
pubmed: 33928266
J Clin Oncol. 2020 Nov 10;38(32):3805-3815
pubmed: 33021872

Auteurs

Lea Naomi Eder (LN)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Danilo Martinovic (D)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Paolo Mazzeo (P)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Christina Ganster (C)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Justin Hasenkamp (J)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Julia Thomson (J)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Arne Trummer (A)

Department of Hematology and Oncology, Städtisches Klinikum Braunschweig, 38114 Braunschweig, Germany.

Detlef Haase (D)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Gerald Wulf (G)

Department of Hematology and Medical Oncology, University Medicine Goettingen, 37075 Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH